SBIR/STTR Research Award
IGF::OT::IGF
Award amount
$208,489Program and phase
SBIR · Phase IAward year
2014Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- AKINA, INC.
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- WTBLC3LE13U1
- Solicitation number
- Not reported
- Topic code
- NCI
Research abstract
Not Available
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Injectable 3-month buprenorphine PLGA microparticle formulation
- Reshapable Hydrogel Tissue Expander
- Intra-Oral drug-eluting adhesive film
- Elastic biodegradable ureteral stent
- Delayed Hydrogel Tissue Expander
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- Mini-reflectance confocal microscope (Mini-RCM) for aiding skin cancer diagnosis and treatment
- Development of small molecule therapeutics targeting AR-V7 for prostate cancer
- Decentralized Clinical Trial of Effectiveness of EnergyPoints App to Guide Acupressure Use for Fatigue and Sleep Disturbances in Cancer Survivors
- Optimized targeted radiotherapy of pancreatic cancer
- Adaptive imaging for pioneering multiplexed spatial profiling of tumors and tissues for cancer research and diagnosis
Research funding history
7 SBIR/STTR records share this UEI (2007–2023). Reported award amounts total $2,191,331. Reported amounts are not federal obligations.
Phases: Phase I, Phase II
Agencies: Department of Health and Human Services